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Thesis Abstract
Mulla, Nancy, M.S., December 1999 Health and Human Performance
Osteoporosis Prevention for Women 25 Years and Younger: Knowledge, Beliefs 
and Practices of Providers at Montana Title X Clinics
Committee Chair: K. Ann Sondag, Ph.D .^*^
The purpose of this study was to conduct an assessm ent of health care 
providers’ knowledge, beliefs and practices regarding osteoporosis prevention 
for women 25 years and younger. In addition, barriers to providing osteoporosis 
prevention information were explored. A questionnaire was distributed to 
providers at Montana’s Title X clinics; follow up telephone interviews were 
conducted for further insight on providers’ needs and clarification of 
questionnaire data.
A combination of descriptive statistics, chi square tests and discriminant 
analyses were run on questionnaire data; follow up telephone interview data 
were qualitatively analyzed. Results indicated most providers believe that 
osteoporosis prevention is important and are well informed about the disease. 
Inadequate calcium intake, lack of exercise, smoking, and the use of Depo- 
Provera® a s  contraception were viewed as the most important risk factors when 
addressing the development of osteoporosis and when screening for 
osteoporosis risk. No specific assessm ent tool for osteoporosis risk was utilized, 
and inconsistencies in screening practices were found. Verbal instruction was 
used most often when providing osteoporosis education, and lack of written 
materials was perceived as a banrier to providing that information. Other 
perceived barriers to providing information included patients’ lack of 
receptiveness to osteoporosis information, the lack of professional education for 
registered nurses, and not enough time with patients. However, no statistical 
significance was found between the number of patients seen per day and 
providers’ perception of time as a  barrier.
The results of this study assisted the Montana Department of Health and Human 
Services in understanding the needs of providers regarding osteoporosis 
prevention. Development of educational materials and services will improve 
providers’ prevention practices at Montana's Title X clinics. Ultimately, 
improving osteoporosis prevention efforts among health care providers will help 
reduce the number of women who suffer from this incurable disease.
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CHAPTER I
Introduction to the Study 
Osteoporosis affects 28 million Americans, 80% of whom are women. An 
estimated $14 billion per year is spent on treatment, which equates to 
$38 million spent each day. Predictions are that up to 41 million people will be 
affected by 2015 if this disease is not addressed (Osteoporosis and Related 
Bone Diseases, National Resource Center (ORBD-NRC), 1999).
There is no cure for osteoporosis. And, while the incidence of 
osteoporosis could be greatly reduced if prevention efforts were focused on 
obtaining peak bone mass in earlier years, most prevention efforts have been 
devoted to decreasing bone loss after the attainment of peak bone density, such 
as in menopause. (Cerrato, 1992; Cadogan, Eastell, Jones & Barker, 1997). 
The importance of focusing prevention efforts on young women is evident- it is 
estimated that even a  5% increase in bone m ass during adolescence and young 
adulthood can reduce the risk of osteoporosis by 40% (Bachrach, 1996). Peak 
bone m ass can be increased by reducing risk factors associated with 
osteoporosis such as smoking, excessive use of alcohol. Inadequate diet and 
eating disorders, lack of exercise, amenorrhea, and calcium and vitamin D 
deficiency. The use of Depo-Provera® for contraception also has been 
associated with decreased bone density in young women (Cromer et al, 1996). 
Efforts to reduce these risk factors should be targeted toward adolescents and
1
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young women who are in their prime years for attaining and maintaining optimal 
bone density (Katzman, 1991 ).
Purpose of the Study 
There is a lack of information on health care providers’ prevention efforts 
for women 25 years and younger. Most research reviewed on providers 
regarding osteoporosis has focused exclusively on postmenopausal women 
(Grisso, Baum & Turner, 1990; Willhite, 1998; Suarex-Almazor, Homik, Messina 
& Davis, 1997). More information is needed regarding providers’ knowledge, 
beliefs and practices in relationship to osteoporosis prevention strategies for 
young women. Therefore, the purpose of this study was to conduct an 
assessm ent of health care providers’ knowledge, beliefs and practices regarding 
osteoporosis prevention for women 25 years and younger. In addition, barriers 
to osteoporosis prevention and education were explored.
Research Questions
1. What do health care providers know about osteoporosis prevention for 
women 25 years and younger?
2. What are health care providers’ beliefs regarding osteoporosis prevention 
for women 25 years and younger?
3. What are health care providers’ current practices regarding osteoporosis 
prevention for women 25 years and younger?
4. What do health care providers perceive to be barriers to disseminating 
osteoporosis prevention Information and education?
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Significance of the Study 
Information from this study provides the Montana Department of Public 
Health and Human Services (DPHHS) Women’s Health Section (WHS) with an 
understanding of providers’ knowledge, beliefs and practices regarding 
osteoporosis prevention for women 25 years and younger. Barriers to 
disseminating osteoporosis prevention information and education have been 
identified, as  well as prevention strategies that may be used by health care 
providers at Montana Title X Family Planning clinics. Ultimately, improving 
osteoporosis prevention efforts of health care providers will help reduce the 
number of women who suffer from this incurable disease.
Delimitations 
The following were delimitations of this study:
1. The study was delimited to health care providers employed at Title X 
clinics in Montana.
2. Data were collected via mailed questionnaires and telephone 
interviews.
3. Data were restricted to respondents’ self report on questionnaires and 
during telephone interviews.
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Limitations
The following limitations existed In this study:
1. Response was limited to the voluntary action of participants filling out 
the questionnaire.
2. Telephone interview data were limited by what they were willing and 
able to share.
3. Data were limited to the participants’ accuracy and honesty when filling 
out questionnaires and when participating In telephone interviews.
Definition of Terms 
Amenorrhea: The abnormal absence or suppression of the menstrual 
discharge (Webster’s, 1965).
Anovulation: The absence of production and discharge of an ovum (egg) 
during the female reproductive cycle (Taber’s, 1989).
Beliefs: A state or habit of mind in which trust or confidence is placed in some 
person or thing (Webster’s, 1965).
Calcitonin: A hormone from the thyroid gland important in bone and calcium 
metabolism (Taber’s, 1989).
Depo-Provera: The pharmaceutical name for Depot Medroxyprogesterone 
Acetate, an injected form of contraception used by many young women 
(Cromer et al, 1996).
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Glucocorticoid: A general classification of adrenal cortical hormones that are 
primarily active in protecting against stress and in affecting protein and 
carbohydrate metabolism (Taber’s, 1989).
Health Care Provider: For the purpose of this study, any person
that may provide counseling, education, treatment or information 
regarding osteoporosis prevention to non-pregnant clients 25 years or 
younger at a Title X clinic or affiliated satellite clinic.
Hyperparathyroidism: Condition due to increased activity of the parathyroid,
which regulates calcium and phosphorus metabolism (Taber’s, 1989).
Hyperprolactinemia: Excess secretion of prolactin thought to be due to 
hypothalamic-pituitary dysfunction, which is usually associated with 
amenorrhea (Taber’s, 1989).
Norplant: A steroid medication implanted under the skin and time released into 
the body to prevent pregnancy (Taber’s, 1989).
Oral contraceptive: Colloquially termed "the pill,” an oral medication consisting 
of chemicals similar to natural hormones (estrogen and progesterone) 
that prevents conception (Taber’s, 1989).
Osteoblast: A cell of mesodermal origin that is concerned with the formation of 
bone (Taber’s, 1989).
Young Women: For the purpose of this study, all non-pregnant women 
25 years or younger.
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CHAPTER II
Review of Literature 
Osteoporosis, or "porous bone," is defined by the National Osteoporosis 
Foundation as "a disease characterized by low bone m ass and structural 
deterioration of bone tissue, leading to bone fragility and an increased 
susceptibility to fractures of the hip, spine, and wrist." It is also defined as 
approximately 25% of bone loss compared to a healthy young adult or, on a 
bone density test, 2.5 standard deviations below normal (National Osteoporosis 
Foundation (NOF), 1999).
Osteoporosis affects 28 million Americans, 80% of whom are women. 
One out of every two women will have an osteoporosis-related fracture in her 
lifetime (NOF, 1999). Although men are also affected, for the purpose of this 
study, review of literature was limited to information relating to women, and the 
focus of the review was on young women, 25 years and younger.
An estimated $14 billion per year is spent on osteoporosis and related 
fractures, which equates to $38 million spent each day. If this issue is not 
addressed, it is predicted that up to 41 million people will be affected by 2015 
(Osteoporosis and Related Bone Diseases, National Resource Center 
(ORBD-NRC), 1999).
Osteoporosis is often referred to as the “silent disease” because bone 
loss occurs without symptoms, and may go undetected until a bone fractures. It 
can strike at any age, but those most affected are women over 45 years of age.
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Menopausal women are at greatest risk because bone loss is accelerated by 
decreased estrogen levels (NOF, 1999). Most literature focuses on treatment 
and prevention of osteoporosis for postmenopausal women. However, studies 
show that acquiring optimal peak bone mass is crucial in reducing the risk of 
osteoporosis-related fractures later in life (Cadogan, Eastell, Jones & Barker, 
1997). Peak bone m ass is acquired before the age of thirty, with the majority of 
bone density being obtained during the first two decades of life (NOF. 1999). 
During these important years, the increase of bone mass can make a significant 
difference; even a 5% increase can reduce the risk of osteoporosis by 40% 
(Bachrach, 1996). If peak bone mass is obtained in earlier years, one has a 
“jump start” on preventing this disease, and minimizes the threat of 
postmenopausal problems (Cerrato, 1992). Osteoporosis is more likely to 
develop if optimal bone mass is not acquired during adolescent years 
(ORBD-NRC, 1999). The focus of prevention, therefore, should be on children, 
adolescents and young women who are in their prime years for attaining and 
maintaining optimal bone density (Katzman, 1991 ).
Bone and Peak Bone Mass 
Bone is a living, complex tissue, made up of mostly collagen and calcium 
phosphate. These two components make bone both strong and flexible. Over 
99% of the body’s calcium is in the bones and teeth (ORBD-NRC, 1999).
Bone tissue development - called remodeling - occurs throughout the life cycle.
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Formation occurs when new bone is added and resorption occurs when old bone 
is removed. Before age 30, formation occurs faster than resorption, with the 
majority of bone mass accumulating during the first twenty years (NOF, 1999; 
Drugay, 1997; NIH, 1994). Infants and children have steady but slow bone 
growth, until puberty. At this time and through adolescence, up to 60% of total 
bone mass is acquired (Katzman, 1991). By age 18, skeletal growth is nearly 
complete, and only a minor (but important) percentage of bone is accumulated 
between ages 18 and 30 (NIH, 1999). After age 30, bone resorption begins to 
exceed formation. This decline is slow and steady until menopause, when at 
this time bone density can be rapidly lost, especially during the first few years 
after menopause. Osteoporosis is more likely to develop if optimal bone mass is 
not attained (QRBD~NRC, 1999). Peak bone mass is affected by many factors 
(NOF. 1999).
Risk Factors of Osteoporosis 
Many factors can interfere with attaining and maintaining peak bone 
mass, increasing risk for osteoporosis. While factors alone cannot predict actual 
fracture risk, they are guidelines for discussion of these issues. Some factors 
can be controlled; others cannot. Multiple risk factors increase the likelihood of 
developing osteoporosis (Drugay, 1997). All risk factors are important in 
osteoporosis prevention.
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Gender. Body Size, and Age
Women are at higher risk for developing osteoporosis. Bone is lost more 
rapidly when estrogen levels are decreased, such as during menopause and 
with menstrual irregularities. Women also have less bone tissue than men 
(ORBD-NRC, 1999). A small, thin-boned woman is at higher risk. Risk 
increases with age, as bone becomes less dense and weaker (NOF. 1999). 
Ethnicitv
Caucasian and Asian women are at highest risk for osteoporosis.
Hispanic and African-American women have lower risk, but are still considered 
to be at significant risk (NOF, 1999).
Genetics and Familv Historv
Genetics and family history affect osteoporosis risk. Studies show that 
bone density in young women is strongly influenced by genetic factors (Matkovic 
et al., 1990). Sixty to 80% of bone mass is attributed to genetic 
predetermination. Women with parents or grandparents who have osteoporosis 
are considered at higher risk (ORBD-NRC).
Alcohol use
Excessive use of alcohol directly affects bone formation. At high blood 
alcohol concentrations, alcohol is toxic to osteoblasts, the cells that make new 
bone (ORBD-NRC NEWS, 1995). A study with a group of long-term alcoholics 
showed a decrease in bone formation during alcohol intoxication; bone formation
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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did return to normal after the cessation of drinking (Griffiths, Parantainen, & 
Olson, 1993). In addition to the effect on bone formation, an excessive alcohol 
intake may replace nutritional foods, thus decreasing important nutrients such as 
calcium and vitamin D (ORBD~NRC NEWS, 1995).
While excessive alcohol consumption has shown to have a negative effect on 
bone formation, there is an association between moderate alcohol consumption 
and an increase in bone mineral content in postmenopausal women. This could 
possibly be due to increased levels of female sex hormones with moderate 
alcohol use (Laitinen & Valimaki, 1991). Calcitonin, a thyroid hormone that 
inhibits bone resorption, has also been shown to increase with a moderate 
alcohol intake (Griffiths, Parantainen & Olson, 1993).
Cigarette smoking
Cigarette smoking increases risk for osteoporosis. Significant bone loss 
has been seen with prolonged smoking in postmenopausal women. Also, low 
bone density has been associated with cigarette smoking in adolescents and 
young adults (ORBD-NRC News, May 26, 1998). Research also suggests 
differences in bone density between nonsmokers and smokers, possibly due to 
other accompanying lifestyle factors for smokers such as a higher consumption 
of alcohol, less physical activity, and/or a sub-optimal nutritional diet. In 
addition, smokers are often thinner than a  nonsmoker and tend to go through 
m enopause earlier than nonsmokers. Postmenopausal smokers have lower
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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estrogen levels than nonsmokers, which may Increase bone resorption. 
Researchers have found that quitting smoking may help decrease smoking- 
related bone loss, even late in life (ORBD'-NRC NEWS, January 19, 1998).
Lack of Exercise
Lack of exercise increases risk for osteoporosis. Regular, weight-bearing 
exercise has been associated with an Increase in bone mineral density 
(Jonnavithula et al., 1993). Also, an inactive lifestyle may put one at higher risk. 
A positive correlation exists between physical activity and increased bone mass. 
More active children may gain 5%-10% more skeletal m ass during adolescent 
growth, which is an important advantage in attaining peak bone mass 
(Peacock, 1991).
Medications
Certain medications increase risk for osteoporosis. Long-term use of 
glucocorticoid can lead to decreased bone density. Anti-seizure medications, 
gonadotropin releasing hormone (GnRH) analogs and aluminum-containing 
antacids can also contribute to bone loss. Other drug therapies that can affect 
bone density are certain cancer treatments and excessive thyroid hormone 
therapies (ORBD'-NRC, 1999).
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Calcium. Vitamin D. Phosphorus and Sodium
Good nutrition is essential for bone growth and maintenance of bone 
mass. Although a balanced diet of all food groups is needed for overall health, a 
number of nutrients are specifically needed for healthy bone. Vitamin A, 
vitamin C, magnesium, zinc, and proteins are all needed for healthy bone, and 
calcium is especially important in bone formation. Ninety-nine percent of the 
body’s calcium is found in the bones and teeth (ORBD-NRC, 1999). Vitamin D 
is important In calcium absorption, phosphorus affects bone mass, and sodium 
plays an important part in calcium addition to the bone.
Calcium.
Calcium is essential for bone growth. Deficiencies in youth can account 
for a 5-10% difference in peak bone mass (Matkovic, 1993). Calcium deposited 
during pubertal years may determine the risk of osteoporosis and fractures later 
in life (Sandler, et al., 1985).
A study conducted with white adolescent girls (mean age, 12.2) showed 
those who had an increase of calcium through milk consumption in their diets 
had statistically significant increases in bone density and bone mineral content 
over an 18-month period (Cadogan et al., 1997). Genetically predetermined 
bone m ass may not be reached in children and adolescents with calcium intake 
levels below 1,000 mg per day (Matkovic, 1993). Also, Sandler et al. (1985) 
studied postmenopausal women, their bone density, and their recall of milk 
consumption (as a calcium source) as children. The results suggest that "milk
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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consumption during childhood and adolescence appears to be needed not only 
for growth and development, but possibly also to assure, within genetic limits, an 
optimal peak of bone mass and thus greater latitude for the maintenance of 
skeletal integrity in the face of bone losses” (p. 274). Furthermore, studies show 
young women are not consuming enough calcium for strong bones (Harel, et al., 
1998; Kasper et al., 1994; Lysen & Walker, 1997; Farley, 1997). A study 
conducted on adolescents and calcium consumption showed that 89% of the 
subjects consumed less than the RDA for calcium, with girls consuming only 
45% of the RDA. Those who were aware of daily requirements consumed more 
calcium on a daily basis (Hare! et al., 1997).
Calcium intake recommendations change over the life span. Demand for 
calcium is greater during childhood and adolescence, during pregnancy and 
breastfeeding, and after menopause. Recommended calcium intakes have been 
studied and adjusted within the past few years (Matkovic, 1995). Calcium 
recommendations from The National Academy of Sciences (1997) and National 
Institutes of Health (1994) are shown in Table 1.
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Table 1. Recommended Calcium Intakes
RECOMMENDED CALCIUM INTAKES (mg/day)
National Academ y of S c iences (1997) National Institutes of Health (1994)
A ges A ges
Birth - 6 months 210
6 m onths -1  year 270 Birth - 6 m onths 400
1 - 3 500 6 m onths -1  year 600
4 - 8 800 1 - 10 8 0 0 -  1200
9 - 1 3 1300 11 -2 4  1 2 0 0 - 1500
1 4 - 1 8 1300 25 - 50 (women & men) 1000
1 9 - 3 0 1000 51 - 64 (women on ERT & men) 1000
3 1 - 5 0 1000 51+ (women not on ERT) 1500
51 -7 0 1200 65 or older 1500
70 or older 1200
P regnant or lactating 1000 Pregnant or lactating 1200 - 1500
1 4 - 1 8 1300
1 9 - 5 0 1000
Calcium amounts are designed to provide optimal intakes for all ages. 
The FDA has set a "percent Daily Value” (%DV), which shows the amount of 
calcium in food on food labels. 100% DV of calcium is 1,000 mg. For example, 
1 4 -1 8  year olds, who require 1300 mg of daily calcium (National Academy of 
Sciences, 1997), would need 130% DV of calcium. To convert % DV to mg, 
multiply the %DV X 1000. For example, one cup of milk has 30% DV - 
.30 X 1000 = 300 - so one cup of milk contains 300 mg of calcium. Table 2 
shows the %DV for many calcium containing foods.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Table 2. Calcium Containing Foods and %Daily Value
Calcium Foods and % Daily Value (DV)
Milk Products (2-3 servings)
Nonfat milk, Ca+ fortified 1 cup 40% DV Collards 74 cup 20% DV
Yogurt 1 cup 35% DV Turnip greens 2/3 cup 15% DV
Milk 1 cup 30% DV Kale 2/3 cup 10% DV
Cheese 1 oz 20% DV Bok choy 74 cup 10% DV
Pudding Vi cup 10% DV Broccoli 1 stalk 6% DV
Cheese spread 2 TBS 15% DV Carrot 1 med 2% DV
Frozen yogurt % cup 10% DV
Cottage cheese 74 cup 6% DV
Vegetables (3-5 servings)
Meat and Bean Group (2-3 servings)
Calcium-processed tofu 
Dry-roasted almonds 
Scrambled eggs 
Baked beans with sauce 
Black-eyed peas
3 oz 60% 
% cup 10% 
2 eggs 8% 
%cup 8% 
% cup 2%
DV
DV
DV
DV
DV
Fruits Group (2-3 servings)
Ca fortified orange Juice 1 cup 30% DV 
Dried figs 2 figs 6% DV
Orange 1 orange 4% DV
Kiwi 2 kiwis 4% DV
Strawberries 8 berries 2% DV
Grain Products
Waffles (4" sq.) 2 waffles 20% DV
Pancakes (5-inch) 3 pancakes 20% DV
Calcium-fortified cereal 1 cup 15% DV 
Calcium-fortified bread 1 slice 8% DV
Corn tortillas 3 tortillas 8% DV
Bread 1 slice 4% DV
Fats, Oils, and Sweets (use sparingly) 
Milk chocolate 1.5 oz bar 8% DV
Mixed Dishes
Cheese pizza (12-inch) 
Macaroni and cheese 
Grilled cheese sandwich 
Lasagna
Soups prepared with milk 
Chili con came with beans 
Taco with cheese 
Tuna salad sandwich 
Chicken noodle soup
74 pizza 25% DV
1 cup 25% DV
1 sand 25% DV
1 cup 25% DV
1 cup 15% DV
1 cup 10% DV
1 taco 10% DV
1 sand 8% DV
1 cup 2% DV
Calcium comes from all different sources, and many foods are now 
fortified with calcium. Milk and other dairy products are considered excellent 
sources of calcium, and are commonly consumed. Many other non-dairy foods 
also contain calcium (see Table 2) (Farley, 1997). Calcium may also be 
consumed by supplementation. Absorption of calcium is most efficient at 
individual doses of 500 mg or less, taken between meals (NIH, 1994).
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Vitamin D.
Vitamin D enhances calcium absorption. This important vitamin facilitates 
the movement of calcium from the intestine to the blood stream and into bone 
(Farley, 1997). Vitamin D can be obtained through diet, supplementation, and 
adequate exposure to sunlight. 400 to 800 lU is the daily recommendation for 
vitamin D (NIH, 1994).
Phosphorus.
Phosphorus is easily obtained and found in many different foods. Milk 
products, meat products and grains can contribute up to 80% of all phosphorus 
in one’s diet (Anderson & Garner, 1996). Phosphorus is also added to food in 
the form of food additives, and is found in cola-type soft drinks (Caivo, 1994). An 
adequate dietary ratio of calcium to phosphorus ranges from 1:1 to 1:2, with a 
value of 1:1.4 being optimal. A high phosphorus, low calcium diet may be 
typical for many young American women, drinking more sugary soft drinks than 
milk and lacking other calcium foods. Calcium to phosphorus ratios tend to 
exceed 1:2 in these diets, and can even get closer to 1:4 (Anderson & Garner, 
1996). When calcium to phosphorus ratios exceed 1:2, peak bone mass may 
be impaired, or bone loss could be accelerated. Studies in animals have shown 
a significant reduction in vertebral bone mass when fed a high phosphorus, low 
calcium diet (Calvo, 1994). Also, studies in young women have shown a mild 
hyperparathyroidism with a high phosphorus, low calcium diet over a period of 
four weeks. This suggests that the persistent changes in parathyroid hormone,
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a calcium and phosphorus metabolism regulator, Is not conducive to optimizing 
peak bone mass (Calvo, 1994). Too much phosphorus intake in relation to 
calcium intake may contribute to low bone mass, which increases the risk of 
osteoporosis (Anderson & Garner, 1996).
Sodium.
Sodium intake may increase risk of osteoporosis. The recommended 
daily allowance (RDA) for sodium is 2,400 mg. Lysen and Walker (1997) found 
that 68.1 % of adolescents surveyed exceeded the RDA. Studies have shown a 
significant positive correlation between high sodium intake and urinary calcium 
excretion in pre-adolescent females. Urinary calcium has a negative impact on 
bone density by reducing calcium addition (Matkovic et al., 1995).
Estrogen Deficiency and Amenorrhea
Estrogen deficiency increases risk for developing osteoporosis.
Decreased levels of estrogen are associated with decreased bone density 
(Drinkwater, Bruemner, and Chesnut, 1990). Osteoporosis can develop in 
young women due to estrogen deficiency, just as it can in postmenopausal 
women. Amenorrhea, or cessation of menstrual periods, is the predominated 
symptom of estrogen deficiency. Menopausal women become amenorrheic as 
their estrogen levels decrease. Other conditions cause amenorrhea in 
adolescents and young adults which can lead to osteoporosis states for this age 
group (Kilbanski, 1994). Hyperprolactinemia and stress-induced anovulation can 
bring on amenorrhea. Also, an insufficient percentage of body fat due to eating
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disorders or excessive exercise can bring on amenorrhea. In any one of these 
situations, estrogen levels may become deficient and risk for osteoporosis 
increases (Kilbanski, 1994). Studies show that prolonged amenorrhea may 
result in irreversible decreases in bone density (Drinkwater, Bruemner, and 
Chesnut, 1990; Jonnavithula et al., 1993). Athletic training and anorexia 
nervosa both affect teens and young adults, and influences amenorrheic states 
(Jonnavithula et al. 1993).
The female athlete.
Up until the 1980’s, amenorrhea was regarded as something that came 
along with being an athlete as a consequence of training. Today, It is looked at 
as an indication of a  problem. Many female athletes are at high risk for 
osteoporosis, not only later in life, but during earlier years, as well. Excessive 
exercise and restricted diets in these young women may cause amenorrhea 
(Skolnick, 1993). Barbara L. Drinkwater, Ph.D., a research physiologist at the 
Pacific Medical Center in Seattle, WA is a pioneer in osteoporosis research. At 
the 40th annual meeting of the American College of Sports Medicine, Drinkwater 
described many cases of amenorrheic athletes. "We don’t see  many with above- 
average bone densities, which one would expect to find in young physically 
active women. More disturbing is that many of these young women have bones 
that are equivalent to the bones of 50-to 60-year-old women" (Skolnick, 1993, p. 
922). Drinkwater also said that approximately half of the amenorrheic athletes
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she and her colleagues studied had bone densities at least one standard 
deviation below the mean bone density for normal women; many had bone 
density levels more than two standard deviations below the mean for normal 
women, which is close to the standard diagnosis for osteoporosis (NOF, 1999). 
According to Drinkwater (1990), previous amenorrheic female athletes who had 
resumed menstruating showed some increase in bone density, but this increase 
plateaued at a level well below normal bone mass for their age group. Normal 
bone mass had not been reached even four years after menstruation resumed. 
Bone loss may also be irreversible. Studies suggest that extended periods of 
amenorrhea may result in permanent decrease of bone density. Longer 
longitudinal studies need to be conducted to assess the possibility of regaining 
normal bone density (Drinkwater, Bruemner & Chestnut, 1990). Amenorrhea in 
female athletes needs to be recognized as a red flag for osteoporosis risk. 
Pre-participation examination may be a good time to screen for possible 
symptoms and risk factors for osteoporosis (Skolnick, 1993).
Anorexia Nervosa.
Anorexia nervosa is characterized by "a weight loss to less than 85% of 
ideal body weight by self-imposed food restriction” (Kilbanski, 1994). This 
disease creates complex problems within the body, and affects many systems 
that contribute to the development of bone loss, including estrogen deficiency 
(Klibanski, 1994). Studies have shown that osteoporosis develops in young
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women with anorexia nervosa (Cundy et al., 1991). Furthermore, bone loss in 
anorexic women is of greater severity compared to other groups of amenorrheic 
women, such as athletes. Up to a 50% reduction in bone mass has been 
reported in anorexic women in their teens and early 20's (Klibanski, 1994).
These women may have sustained permanent bone loss, which will put them at 
a  higher risk for osteoporosis throughout their lives (Klibanski, 1994; Drinkwater, 
Bruemner and Chesnut, 1990; Jonnavithula et al., 1993; Skolnick, 1993). 
Contraception Use
The risk of osteoporosis associated with contraception methods has just 
recently been studied. Although research is limited, studies show there may be 
a relationship between certain types of contraception and bone density. With 
the use of Depo-Provera, a progesterone contraceptive, most women become 
amenorrheic (Cundy et al, 1991). Cromer et al. (1996) conducted a study 
comparing bone densities in girls, ages 12-21, before and after treatment of 
hormonal contraceptives (Depo-Provera, Norplant, and oral contraceptives) and 
bone densities in a control group receiving no hormonal treatment. After one 
year of treatment, all groups increased their mean bone density except for the 
Depo-Provera group, whose mean bone density decreased significantly 
compared to the control group; after two years of treatment, mean bone density 
decreased by 3.12% in the group receiving Depo-Provera, whereas the control 
group had an increase of 9.49% in mean bone density, and the group using
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Norplant also had 9.33% Increase in mean bone density as well. Oral 
contraceptive users were not assessed  at two years because no person in the 
group continued taking oral contraception. Findings suggest that "levels of 
estrogen associated with Depo-Provera therapy may not be adequate for girls of 
this age to produce optimal bone mineralization" (Cromer et âl., 1996, p. 675). 
Another study conducted by Cundy et al. (1991) showed a 7.5% decrease in 
bone density among Depo-Provera users. In a follow-up study using some of 
the same subjects, a mean gain of 6.4% was seen after discontinuation of Depo- 
Provera, This study suggests that bone loss may be reversible after treatment 
ceases (Cundy et al., 1993). It is very important to note that these two studies 
by Cundy et al. were confined to adult women, all of whom were 25 years or 
older (1991 & 1993). Since over half of bone mass is achieved during 
adolescent years (Cadogan, 1997), an increase in bone density during these 
years seem s almost certain. The decrease of bone density in adolescent Depo- 
Provera users raises questions and concerns regarding osteoporosis risk. At 
present, there are no conclusions on adolescents and the effects on bone 
density with long term use of Depo-Provera. Also, no studies have been 
conducted on bone density and adolescents who have stopped receiving Depo- 
Provera. “A future direction for research in this area would be to examine the 
degree to which adolescents regain lost bone after discontinuing this 
contraceptive method and whether estrogen replacement might attenuate bone 
loss during long-term use of Depo-Provera” (Cromer et al., 1996, p. 676).
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Detection of Osteoporosis 
Osteoporosis may go undetected until a fracture occurs. A bone mineral 
density (BMD) test is a clinical test that measures bone density. This test can 
confirm a diagnosis of osteoporosis. There are different types of BMD tests; 
some measure spine, wrist, and hipbone density, and others measure density In 
the heel or hand (Drugay, 1997). Diagnostic criteria using standard deviations 
(SD) from the norm have been established by the World Health Organization. 
Criteria for bone mineral density values for osteoporosis are set at any value 
greater than 2.5 SD below the young adult mean (NOF, 1999). These tests are 
non-invasive and safe. Most BMD tests are mainly recommended to 
postmenopausal women (NOF, 1999). Literature suggests that tests be used for 
young women indicating a high number of risk factors (Lysen and Walker, 1997).
Therapeutic Medications 
A number of medications are available for osteoporosis, both for prevention 
and treatment. Medications currently approved by the FDA for use in 
postmenopausal women include estrogen, calcitonin, alendronate, and 
raloxifene (ORBD-NRC, 1999). Treatments under investigation include sodium 
fluoride; vitamin D metabolites; parathyroid hormone; other bisphosphonates 
and selective estrogen receptor modulators (NOF, 1999). Literature suggests 
that hormone replacement therapy also be used for young women at higher risk 
for osteoporosis, such as those with amenorrhea. To date, however, no data is
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available on dosages for younger women and how effective this treatment would 
be for increasing bone density (Skolnick, 1993).
Prevention
There is no cure for osteoporosis. Acquiring and maintaining optimal 
bone m ass in young women is critical for prevention. Literature shows that most 
efforts in osteoporosis prevention have been devoted to decreasing bone loss 
after the attainment of peak bone density, such as in menopause. However, 
given that increased peak bone density reduces osteoporosis risk in later years 
(Matkovic, 1995), attention must be given to factors that affect peak bone mass. 
Emphasis on the latter is directed toward children and adolescents, as the 
majority of peak bone mass is attained during these years. Osteoporosis 
prevention needs to begin decades before women experience menopause.
The best prevention against osteoporosis is attaining optimal peak bone 
mass and maintaining optimal bone density (Cadogan, Eastell, Jones, & Barker,
1997). Peak bone mass can be more easily attained and maintained by 
reducing changeable risk factors associated with osteoporosis. “Adolescents 
should be strongly encouraged to adopt healthy lifestyles, characterized by 
adequate calcium Intake, moderate weight-bearing exercise, limited high-sodium 
intake, and an absence of eating disorder, smoking and alcohol consumption” 
(Lysen and Walker, 1997). As the importance of prevention has become more
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evident, programs directed toward children, adolescents and young adults are 
being studied, developed, and implemented.
Osteoporosis Prevention Strategies 
Most literature available on osteoporosis prevention is geared toward 
postmenopausal women. There Is, however, an increasing focus on prevention 
strategies for adolescents and young women. Lysen & Walker (1997) list 
several suggestions for osteoporosis prevention strategies:
• Prevention educational materials for use by health educators, school 
nurses, physical education teachers, dietitians, health care providers and 
parents need to be developed.
• Risk assessm ents can provide valuable information for physicians and 
other health professionals, used as screening tools for increased risk for 
osteoporosis.
• Food industries and agencies can also be involved by promoting benefits 
of improved bone health (Lysen & Walker. 1997).
It is evident that researchers agree that many avenues can be utilized to 
get important osteoporosis prevention information to youth and effectively impact 
their beliefs and behaviors regarding osteoporosis (Harel, et al., 1998; Kasper et 
al., 1994; Drugay, 1997; Lysen & Walker, 1997; ORBO-^NRC NEWS, 1997). 
Perceptions Among Young Women
To develop an effective program, it is important to know how young 
women perceive osteoporosis, what they believe to be true, what their attitudes
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are, and their behaviors toward osteoporosis prevention. Kasper, et al. (1994) 
found that, among college women (mean age of 19.6 years; 92% white), the 
more information they had seen or heard about osteoporosis, the more likely 
they were to correctly identify risk factors, with most identifying low calcium 
intake and lack of physical exercise as risk factors. In spite of having knowledge 
regarding osteoporosis and being able to identify risk factors, there was not a 
statistical significant correlation between these two factors and behaviors. The 
majority of the young women were not consuming the recommended daily 
amount of calcium, and were lacking sufficient exercise for osteoporosis 
prevention. In addition, the study documents that "young women believe that it 
is unlikely that osteoporosis will develop in them. Women are also less 
concerned about osteoporosis, believe that they are less responsible for 
osteoporosis developing, and believe that osteoporosis is less serious than 
other common causes of morbidity and mortality in women” (p. 701).
Another study done with adolescents (mean age of 14.8, 52% female) 
showed that while the youngsters were aware of major health benefits of 
calcium, they lacked specific Information about daily requirements, sources, and 
amounts. Eighty-nine percent of the adolescents consumed less than the RDA 
for calcium, with girls consuming an average of 536 mg daily, which is over 700 
mg lower than the recommended daily intake for this age group (Harel, et al.,
1998). Another study conducted by ORBD-NRC, NOF, and others (1998),
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found that many girls have limited knowledge about bone formation, bone health, 
and osteoporosis, or what they can do to prevent osteoporosis; only 13% of girls 
12-19 years old get enough calcium to build strong bones; and 53% of young 
women ages 12-21 exercise less than three times a week.
Educational Programs
Currently, there are educational programs being developed and 
implemented throughout the United States. NIH, NOF, and ORBD~NRC have 
developed and disseminated invaluable Information regarding osteoporosis. 
Educational programs targeting younger populations are just recently being 
implemented. The most familiar educational program, the “milk mustache” 
campaign, is nationwide and working to reach teenagers through magazine 
advertisements. This campaign uses famous people with whom teens identify to 
promote calcium intake through milk consumption. The campaign also uses 
radio public service announcements, book covers, and an Internet site 
(http://www.whymilk.com) (National Institute of Child Health and Human 
Development (NICHD), 1999).
Another educational program, “Crash Course on Calcium,” was 
developed by the Milk Processor Education Program and the National Dairy 
Council with technical assistance from NICHD, and the American Academy of 
Orthopedic Surgeons (AAOS). This program gives teachers tools to educate 
teens on osteoporosis and prevention. An Internet site is available at
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www.vpw.com, and information can be obtained by calling 1-800-WHY-MILK 
(NICHD, 1999).
In addition to “A Crash Course on Calcium”, NICHD has another 
educational campaign called "Milk Matters.” This campaign educates young 
people about the importance of calcium for building strong bones and a health 
body. Information is available at the Internet website www.nlh.gov/nichd .
Furthermore, many states are developing educational awareness 
programs for children, adolescents, and young adults. Currently, The 
M assachusetts Department of Public Health has established a comprehensive 
program that includes information developed for teachers and health educators 
to educate and inform school age girts and teens. Included in this information is 
a risk assessm ent for young women (Massachusetts Department of Public 
Health, 1999).
Health Care Providers and Osteoporosis Prevention
Health care providers may have the opportunity to educate young women 
about osteoporosis prevention. Many studies suggest that physicians and other 
health care workers, including pharmacists, nutritionists, and nurses should be 
involved in educating young women about osteoporosis prevention (Harel et al., 
1998: Kasper et al., 1994; Drugay, 1997; Willhite, 1998; ORBD-NRC NEWS 
YOU CAN USE, 1999). However, some of these sam e studies show little 
information is actually received from health care providers (Harel et al., 1998;
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Kasper et al., 1994). Harel et al. (1998) reported only 38% of those surveyed 
discussed health benefits of calcium with their health care provider (p. 226). 
Similarly, Kasper et al. (1994) reported no significant relationship between 
current or previous contraceptive use and having received information about 
osteoporosis from a health care provider (p. 700). Kasper et al. (1994) suggest 
that "health care providers have either missed opportunities to disseminate 
osteoporosis information to young women or such information has not been 
received and retained by them" (p. 701). It is also possible that providers have 
disseminated osteoporosis information, but young women do not perceive 
themselves as susceptible to the disease (Kasper, et al., 1994).
To date, all research found on providers’ attitudes, knowledge, beliefs, 
and practices regarding osteoporosis has exclusively focused on 
postmenopausal women (Grisso, Baum & Turner, 1990; Willhite, 1998; Suarex- 
Almazor, Homik, Messina, & Davis, 1997). Findings from one of these studies 
suggest that “individual physician perceptions may be more influential than 
patient characteristics in the decisions physicians make when preventing and 
managing osteoporosis” (Suarex-Almazor, Homik, Messina, and Davis, 1998,
p. 1106).
Barriers to providing osteoporosis prevention information.
The U.S. spends more on health care than any other country. The 
majority of this spending focuses on caring for patients in the end stages of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
29
disease. Only 3% of U.S. health care expenditures are spent on prevention 
(ORBD-NRC, 1999). Possible reasons why health care practices have not 
focused on prevention include:
• Uncertainty about effective strategies for implementing preventive care in 
clinical practice
• Lack of evidence about the effectiveness of preventive interventions in reducing 
morbidity and mortality
• Confusion about the conflicting recommendations of different organizations
• Lack of time for health promotion counseling in busy clinical settings
• Inadequate reimbursement for preventive services
• Little evidence of the cost-effectiveness of some preventive measures
• Poor preparation in medical school and postgraduate clinical training for
practicing health promotion and disease prevention
(ORBD-NRC NEWS, Guidelines to Clinical Preventive Services, April 8, 1996).
Health care providers’ needs for providing osteoporosis prevention 
information to vounq women.
Information regarding providers’ needs in relationship to osteoporosis 
prevention in children, adolescents and young adults has not been found. The 
M assachusetts Department of Public Health did provide a partial list of survey 
questions that had been asked of pediatricians and pediatric clinicians. It is 
evident that more data are needed regarding health care providers’ needs in 
relationship to osteoporosis prevention.
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Methodology
The purpose of this study was to conduct an assessm ent of health care 
providers’ knowledge, beliefs and practices regarding osteoporosis prevention in 
women 25 years and younger. In addition, barriers to disseminating 
osteoporosis prevention information and education were identified.
Description of Target Population 
The population investigated in this study was health care providers 
employed at Montana Title X Family Planning primary and affiliated satellite 
clinics. A health care provider, for the purpose of this study, is defined as any 
person that may provide counseling, education, treatment or information 
regarding osteoporosis prevention to non-pregnant clients 25 years or younger. 
There are 15 primary Title X clinics and 17 satellite clinics in Montana (see 
Appendix A). Approximately 75 health care providers were eligible to 
participate.
Procedures
Selection of Sample 
Questionnaire.
An introductory letter was sent to the clinical director at each Title X 
primary clinic (see Appendix B). This letter explained the purpose of the study 
and the assessm ent process. Directors were asked to provide the names and 
titles of health care providers in their clinics who may provide counseling,
30
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education, treatment, or information regarding osteoporosis prevention to clients 
25 years or younger. Directors recorded these names on a response form 
(see Appendix C) and returned them in a postage paid envelope. As incentive, 
DPHHS agreed to substitute participation in this study for the Title X Internal 
Medical Audit Requirement. Survey results are available to all Title X clinics.
Telephone interviews.
After analysis of the questionnaire data, a telephone interview response 
form was sent to each health care provider who returned a questionnaire (see 
Appendix D), with a return postage-paid envelope included. Returned response 
forms were numbered and simple random sampling was used for selecting 
participants (McMillan & Schumacher, 1997, p. 166). The number of interviews 
to be conducted was predetermined to be 20% of the total number of 
questionnaires returned.
Instrumentation
Questionnaire.
The questionnaire was comprised of a series of fourteen questions 
designed to pinpoint the knowledge, beliefs and practices of health care 
providers regarding osteoporosis prevention for women 25 years and younger. 
Possible barriers to disseminating osteoporosis prevention information and 
education were also addressed (see Appendix E). The review of literature was 
an integral part of development. While no questionnaire was found specifically
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targeting osteoporosis prevention for women 25 years and younger, two surveys 
focusing on menopausal osteoporosis were located. Questions from these 
existing tools were modified, and additional items were developed. The 
Instrument was reviewed by experts for face and content validity, and revisions 
were made accordingly. Finally, the questionnaire was pilot tested among a 
group of health care providers.
Telephone interviews.
Structured telephone interviews were used to collect additional 
information regarding health care providers’ needs. This type of interviewing 
uses standardized, open-ended interview questions, and are asked in the same 
order, thus reducing interviewer effects and bias (Mcmillan & Schumacher, 1997, 
p. 447). After analysis of questionnaire data, fifteen interview questions were 
designed to further clarify questionnaire data, and to gain a deeper 
understanding of providers’ knowledge, beliefs and practices regarding 
osteoporosis prevention (see Appendix F). Items were grouped by topic and 
arranged to ensure flow of the interview, as suggested by Gilmore & Campbell 
(1996). An introduction and conclusion were developed to ensure consistency 
in the interview process (see Appendix G).
Data Collection
Questionnaire.
After approval by the UM Human Institutional Review Board (see 
Appendix H), questionnaires were sent via postal mail to each health care
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provider identified by clinical directors. Participants completed the survey and 
returned it in the provided postage paid envelope, which was coded for the 
purpose of follow up. Upon return, the questionnaire was separated from the 
envelope, and the code number recorded. No identifying information was 
recorded on the questionnaires, maintaining the anonymity of participants. Two 
weeks after the Initial mailing, follow up telephone calls were conducted, 
encouraging those who had not returned the questionnaire to do so.
Telephone interviews.
Structured telephone interviews were conducted. The health care 
provider was telephoned during the time indicated on the interview response 
form (see Appendix D). The interview began with the recited introduction (see 
Appendix G), and the researcher proceeded through the interview schedule (see 
Appendix F). As each question was answered, written notes were taken. The 
participant was given all the time needed to answer the question to her 
satisfaction. Each session lasted approximately 1 0 -1 5  minutes, as suggested 
by Gilmore & Campbell (1996, p.31). The interviews were audio-taped with a 
recording device from UM Instrumental Media Services. The recorded tapes 
were used to clarify written notes when needed. Immediately following each 
interview, the general impression and tone of the interview was noted, as well as 
any other information deemed pertinent for data analysis. Interviews were 
conducted over a five-day period.
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Data Analysis
Questionnaire.
Questionnaire responses were statistically analyzed using an SPSS 
computer program, which included a  descriptive analysis of health care 
providers’ knowledge, beliefs and practices regarding osteoporosis prevention in 
women 25 years and younger. Barriers to disseminating osteoporosis 
prevention information were also identified. For question #10, a discriminant 
analysis was conducted to evaluate the difference between providers’ responses 
to “not enough time with client” as a barrier to providing osteoporosis prevention 
information and the average number of patients seen per day. Furthermore, a 
total of 37 chi square tests were conducted to evaluate the differences between 
providers’ responses to Items and the provider’s age, title, or years in practice 
for questions #one through #seven, #10, and #11. For the purpose of this 
study, unless otherwise specified, these variables were divided into the following 
categories:
Age Title Years in Practice
20-39 years 
40-49 years 
50+ years
Registered Nurse (RN) 
Nurse Practitioner (NR) 
Other (see Results, “titles")
2-5 years 
6-10 years 
11 -20 years 
20+ years
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
35
Telephone interviews.
Telephone interview data was qualitatively analyzed to interpret recurring 
patterns and themes of each interview question. Predetermined categories used 
in the interview schedule included:
• screening criteria and practices
• m essages regarding osteoporosis prevention
• age groups most important for osteoporosis prevention
• number of patients and influence of education practices
• barriers to disseminating information and influence of these 
barriers on educational practices
• educational information and tools used
• any additional information noted by participants
Immediately following each interview, the general Impression and tone, 
along with any significant data, was noted on the Interview schedule, and data 
was read briefly for initial informal analysis. Immediately following the 
completion of the last interview, formal analysis began, and was conducted as 
suggested by McMillan & Schumacher (1997, p.508-523). Each category was 
analyzed separately. First, category data was read in its entirety from all 14 
Interviews. Then, data from each question was transferred to an organizing grid 
(see Appendix I), constructing an integrative diagram. Data segments were sub­
categorized, and placed in a corresponding box according to topic. Patterns 
were identified as data segments were classified, and themes emerged.
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Results
The purpose of this study was to conduct an assessm ent of health care 
providers’ knowledge, beliefs and practices regarding osteoporosis prevention in 
women 25 years and younger. In addition, barriers to disseminating 
osteoporosis prevention information and education were identified.
Questionnaire
Demographics
Questionnaires were sent to 74 health care providers. Sixty-nine 
providers responded, for a return rate of 93%. Five questionnaires were not 
returned; two providers were no longer employed at a Title X clinic, two 
providers did not fill out the questionnaire as it did not pertain to them, and one 
provider did not return the questionnaire for unknown reasons.
Participants’ titles.
Participants’ titles included seven groups; registered nurses (RN), nurse
practitioners (NR), clinic directors, health educators, medical doctors (MD).
licensed practical nurses (LPN), and physician assistants (PA). The following is
a breakdown of the participants (n=69):
52.2% (n=36) were RNs 
29.0% (n=20) were NPs 
4.3% (n=3) were clinic directors 
2.9% (n=2) were health educators 
4.3% (n=3) were MDs 
2.9% (n=2) were LPNs
1.4% (n=1 ) were PAs.
36
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Participants’ gender and age.
Ninety-seven percent (n=67) of the participants were female, and 2.9% 
(n=2) were male. Participants’ ages were grouped as follows (n=69):
• 2.9% (n=2) were 20 - 29 years of age
• 17.4% (n=12) were 30 - 39 years of age
• 47.8% (n=23) were 40 - 49 years of age
• 31.9% (n=22) were 50 years or older
Years in practice.
Years in practice ranged from one to 45 years, and the average was 13.9
years. The following is a breakdown of years in practice (n=64):
2.8% (n=2) had practiced less than 2 years 
18.7% (n=13) had practiced 2 - 5  years 
27.3% (n=19) had practiced 6 - 1 0  years 
18.7% (n=13) had practiced 1 1 -2 0  years 
24.2% (n=17) had practiced more than 20 years
Number of patients seen per dav and percentage of patients seen who
are women 25 vears and vounaer.
The number of patients seen per day ranged from one to 30, with an 
average of approximately 12 patients per day. The majority (71.4%) saw nine or 
more patients per day (n=63). Percentage of patients seen by providers who 
were women 25 years and younger ranged from 10% to 100%, with an average 
of 62.38% (n=65).
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Descriptive Analysis
Frequencies of responses are listed below for questions one through 
twelve. Responses to questions #13 and #14 can be found In Demographics 
(see above). Functional discriminant analysis results (see question # 1 0 ) and 
statistically significant chi square results (see questions #1, #7, and #10) are 
also reported.
Question #1: “ In general, how  w ould  you  rate the Importance o f  
osteoporosis prevention?”
A four-point LIkert Scale of “not important,” “somewhat important,” 
“important,” or “very Important” was used for response categories. Responses 
are as follows(n=69):
* 1.4% (n=1 ) - not important
* 4.3% (n=3) - somewhat important
• 14.5% (n=10) - important
• 79.7% (n=55) - very Important
A chi square test showed a statistical difference between beliefs of the 
importance of osteoporosis prevention and titles of providers (p < .001 ).
Providers with titles in the “other “ category rated the general importance of 
osteoporosis prevention as less important than did registered nurses or nurse 
practitioners. Of those who responded "not important” or “somewhat important,” 
two were medical doctors and two were clinical directors.
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Question  #2.* "/#i y o u r opinion, which o f  the fo llow ing  scenarios is  
pre ferred fo r  osteoporosis p revention?”
Participants were given three options and asked to check one. 
Responses are as follows (n=68);
72.5% (n=50) - attaining peak bone mass before the age of 30 
14.5% (n=10) - preventing bone loss with calcium supplementation 
after age 30
11.6% (8) - estrogen replacement therapy during menopausal 
years
Question #3: “Rate each o f  the fo llow ing  risk  factors in terms o f its  
im portance in con tribu ting  to the development o f osteoporosis.”
This question included 12 risk factors that were rated by importance. A 
four-point Likert Scale of “not important,” “somewhat Important,” “important," and 
"very important" was used for response categories. See Table 3 for responses 
to each risk factor.
Table 3. Importance of Risk Factors
Risk factors contributing 
to the development of 
osteoporosis
Not
Important
% #
Somewhat
Important
% #
Important 
% #
Very
Important
# %
Total # of 
responses
n
a. Inadequate calcium 0 0 2.9 2 20.3 14 72.5 50 66
b. Lack of exercise 0 0 10.1 7 33.3 23 53.6 37 67
c. Smoking 0 0 7.2 5 31.9 22 53.6 37 64
d. Depo-Provera® use 1.4 1 10.1 7 46.4 32 36.2 25 65
e. Disordered eating 0 0 13.0 9 36.2 25 43.5 30 64
f. Thin boned / small frame 5.8 4 10.1 7 46.4 32 33.3 23 66
g. Family history 1.4 1 17.4 12 36.2 25 39.1 27 65
h. Vitamin D deficiency 0 0 21.7 15 31.9 22 42.0 29 66
i. Amenorrhea 2.9 2 26.1 18 30.4 21 33.3 23 64
j. Excessive alcohol use 2.9 2 30.4 21 34.8 24 24.6 17 64
k. Ethnicity 1.4 1 36.2 25 42.0 29 14.5 10 65
1. Oral contraceptive use 44.9 31 26.1 31 4.3 3 4.3 3 65
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An additional option labeled “other" was provided for participants to write 
in factors not already listed. Comments included "caffeine intake,” "soft drink 
intake," “steroid use," "low level of estrogen with no estrogen replacement," and 
“knowledge/education of Ca+ importance."
Question  # 4: “How receptive do you  th ink women 25 years and younger 
are to inform ation/education regarding osteoporosis prevention?”
A four-point Likert Scale of "not receptive," “somewhat receptive,” 
"receptive,” and “very receptive” was used for response categories. Responses 
are as follows (n=69):
• 20.3% (n=14) - not receptive
• 60.9% (n=42) - somewhat receptive
• 17.4% (n=12) - receptive
• 1.4% (n=1 ) - very receptive
Question  #5; “ What is  the m ost im portant osteoporosis prevention  
message to give women 25 years and younger about phys ica i activ ity? ”
Participants were given three options and asked to check one.
Responses are as follows (n=69):
• 94.2% (n=65) - engage in exercises such as  weight lifting or 
walking
• 5.8% (n=4) - engage in exercises such as swimming or bicycling
• 0% (n=0) - maintain good posture
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Question  #6: “How m any m illigram s o f  calcium  w ould  you  recomm end fo r  
women 25 years and younger? ”
Answers were written in milligrams daily. Responses ranged from 350 mg 
to 2000 mg, with an average response of 1136 mg, and a mode of 1200 mg 
(36.4%). The following is a breakdown of responses (n=66):
6% (n=4) reported between 0 - 500 mg 
4.5% (n=3) reported between 501 - 999 mg 
66.7% (n=44) reported between 1000 -1500 mg 
22.7% (n=15 ) reported between 1501 -1500 mg
Question  # 7: “Rate each o f  the fo llow ing  age groups In terms o f Its 
Im portance In educating about osteoporosis prevention.”
Five age groups were rated by importance. A four-point Likert Scale of 
“not important,” “somewhat important," “important," and “very important" was 
used for response categories. See Tables 4 for responses to each age group.
Table 4. Importance of Osteoporosis Prevention Education by Age Group
Age groups Not
Important 
% #
Somewhat 
important 
% #
Important 
% #
Very
Important
% #
Total # of 
responses 
n
Pre-teen
(8 -1 2 )
7.2 5 24.6 17 36.2 25 30.4 21 68
T een
(1 3 -1 9 )
0 0 10.1* 7 21.7 15 66.7 46 68
Early adult 
(20 - 40)
0 0 1.4 1 14.5 10 84.1 58 69
Mid life 
(41 - 65)
0 0 2.9 2 13.0 9 84.1 58 69
Elderly 
(66 & up)
0 0 5.8 4 23.2 16 69.6 48 68
’‘Statistical difference between belief and title (p < .01).
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A chi square test showed statistical difference in providers’ beliefs 
regarding the importance of osteoporosis prevention education for teens 
(1 3 -1 9 ) and providers' titles. Providers with titles in the "other” category rated 
the importance of education for teens (13 - 19) as less important than did 
registered nurses or nurse practitioners. Of those who responded "not 
important " or “somewhat important.” two were medical doctors, one was a clinical 
director, and one was a health educator.
Question  #  8: "Do you  believe that you  as a health care p rov ide r are the 
best source o f osteoporosis prevention inform ation fo r  women 25 years  
and younger? ” .
Responses are as follows (n=69):
• 73.9% (n=51) responded “yes”
• 4.3% (n=3) responded "no”
• 21.7% (n=15) responded “not sure”
A second question was asked, “i f  no o r no t sure, who o r what w ou ld  
be the best source?”  Responses included "teacher” (n=3), "parents or family" 
(n=7), "peers” (n=3), "school nurse or school programs” (n=7), "family 
practitioner, OB/GYN, or health care provider” (n=2), “media" (n=5), “public 
education” (n=1), “dietician” (n=1), “repeated sources” (n=1), and “universal 
access” (n=1).
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Question  #  9: “How often do you  use screening criteria  to determine which  
patien ts receive inform ation about osteoporosis p revention?”
A four-point Likert Scale of "never," “rarely," “sometimes," and “often” was 
used for response categories (n=69). Responses are as  follows:
• 20.3% (n=14) "never" use screening
• 11.6% (n=8) "rarely” use screening
• 27.5% (n=19) "sometimes” use screening
• 40.6% (n=28) use screening “often”
A follow up question was asked, “ i f  you  use screening criteria, what 
patien t behaviors o r  characteristics are inc luded?”  Twelve behaviors or 
characteristics were listed, and participants were asked to check those that 
applied. See Table 5 for responses.
Table 5. Behaviors or Characteristics Used for Screening Criteria
Behavior or characteristic Checked as 
“used”
% #
Total #  of 
responses 
n
a. Inadequate calcium 89.7 52 58
b. Lack of exercise 79.3 46 58
c. Smoking 81.0 47 58
d. Depo-Provera® use 86.2 50 58
e. Disordered eating 74.1 43 58
f. Thin boned I small frame 67.2 39 58
g. Family history 72.4 42 58
h. Vitamin D deficiency 50.0 29 58
i. Amenorrhea 65.6 38 58
j. Excessive alcohol use 51.7 30 58
k. Ethnicity 34.5 20 58
1. Oral contraceptive use 41.4 24 58
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An additional option labeled “other” was provided for participants to write 
in screening criteria not already listed. Comments included; “diabetes, thyroid, 
endocrine related,” “soft drink intake,” "being female” and “caffeine intake, other 
vitamins.”
Question  #  10: “ To what extent do you  agree that the fo llow ing  are barriers  
to  yo u  p rov id ing  osteoporosis prevention Inform ation to  women 25 years 
o r younger? ”
Eight possible barriers were rated In terms of agreement. A four-point 
Likert Scale of “strongly disagree," “disagree,” “agree” and “strongly agree” was 
used for response categories. See Table 6 for responses to each barrier.
Table 6. Barriers to Providing Osteoporosis Prevention Information
Possible barriers to providing 
Information
Strongly 
Disagree 
% #
Disagree 
% #
Agree 
% #
Strongly 
Agree 
% #
Total #  
responses 
n
“Lack of written materials for 
patients {i.e. brochures)" 5.8 4 20.3 14 55.1 38 11.6 8 64
“Not enough time with client" 5.3 4 34.8 24 36,2 25 15.9 11 64
“Osteoporosis prevention is not 
supported through grants" 7.2 5 29.0 20 44.9 31 7.2 5 61
“Osteoporosis prevention is not 
reimbursable through insurance" 8.7 6 21.7 15 34.8 24 13.0 9 54
“Lack of education in my 
professional training" 31.9 22 37.7 26 17.4* 12 4.3 3 63
"Not a priority for me during office 
visit" 26.1 18 39.1 27 15.9 11 4.3 3 59
“Insufficient research making the 
case for prevention ..." 36.2 25 40.6 28 11.6 8 2.9 2 63
“Osteoporosis prevention is not 
supported by clinic admin." 29.0 20 53.6 37 7.2 5 0 0 62
’‘Statistical difference betw een belief and  title (p<.01)
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An additional option labeled “other” was provided for participants to write 
In barriers not already listed. Comments included: "other more pressing issues 
in age group," “already too much info to give," "useful education, families and 
offspring," “need to self-train, brochures would help."
A discriminant analysis showed no statistical difference between 
providers who responded that “not enough time with client” was a barrier and the 
average number of patients seen per day.
A statistical difference was detected by a chi square test between 
providers who responded “lack of education in my professional training” was a 
barrier and provider’s titles (p<.01). Nurses reported more often than nurse 
practitioners that they believed they lacked adequate education.
Question  #  11: To what extent do yo u  agree that the fo llow ing  are barriers  
to wom en’s  receptiveness to osteoporosis prevention Inform ation?
Four possible barriers were rated in terms of agreement. A four-point 
Likert Scale of "strongly disagree”, "disagree”, "agree” and “strongly agree” was 
used for response categories. See Table 7 for responses to each barrier.
An additional option labeled “other” was provided for participants to write 
in perceived barriers not already listed. Comments included "receive so much 
other info it’s hard for them to hear more", “attitude of invincibility", “a lot of time, 
young women believe they are young forever - 'I’ll worry about it later’.”
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Table 7. Barriers to Women’s Receptiveness to Osteoporosis Prevention
Possible barriers to 
receptiveness
Strongly
Disagree
Disagree Agree Strongly
Agree
Total #  
responses
% # % # % # % # n
“Young women don’t believe 
they are susceptible..." 1.4 1 2.9 2 44.9 31 49.3 34 68
“Young women do not have 
knowledge of risks of osteo.” 1.4 1 8.7 6 52.2 36 37.7 26 69
“Osteoporosis prevention is not 
a priority for the patient" 2.9 2 8.7 6 63.8 44 23.2 16 68
“Chronic disease in general is 
not a priority for young women " 4.3 3 7.2 5 49.3 34 37.7 26 68
Question  #  12: i f  you  prov ide  inform ation regarding osteoporosis  
prevention to women 25 years and younger in what m anner do you  provide  
it?
Seven informational tools were listed, and participants were asked to 
check those that applied. Participants also had the option of checking "question 
does not apply." See Table 8 for responses.
Table 8. Manner in which Information is Provided
M anner in which C hecked Total #  Of
information m ay be responses
provided % # n
“ d o es  not apply” 4.3 3 3
a. Verbal Instruction 93.8 61 65
b. Brochures 46.2 30 65
c. Calcium intake charts 40.0 26 65
d. Posters in office 27.7 18 65
e. Informational booklets 20.0 13 65
f. Promotional handouts 18.5 12 65
g. Informational videos 1.5 1 65
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An option labeled “other” was provided for participants to write in tools 
used not already listed. Comments included: “general nutritional counseling, 
proper Ca+, general fitness, healthy lifestyle and exercise”, "diet sources, 
alternative supplement choices,” “clinic developed info sheet,” "on request,” 
individual counseling,” and “have Ca+ on hand for free distribution.”
Telephone Interviews
Forty-three telephone interview response forms were returned, for a 64% 
return rate. Fourteen participants were initially selected; two interviewees from 
the original selection were not available during the interview process, so were 
randomly replaced with two other names from the remaining response forms. 
Fourteen telephone interviews were conducted, which constituted 20% of the 69 
questionnaires returned; seven participants were RNs, four were NPs, one was 
an LPN, one was an MD, and one was a clinical director; eight different primary 
clinics and four affiliated satellite clinics were represented. Results are reported 
below by interview question.
Question # la :  How do you  determ ine whether o r n o t to screen a patient
regarding osteoporosis?
Screening was mainly determined by reason for the visit. Screening 
occurred more during initial visits and annual exams, and with patients using 
Depo-Provera®. Patients being seen for a  prescription refill, a sexually
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transmitted disease (STD) check, or for a pregnancy test were given less priority 
for screening for osteoporosis risk.
# 1b: What criteria are used in screening?
Criteria used for screening were Depo-Provera® use, inadequate calcium 
intake, the lack of exercise, and smoking. The information was obtained from a 
nutritional intake form and a health history form, which is filled out by each 
patient during an initial visit or annual exam. No assessm ent tool specific to 
osteoporosis risk screening was used by any provider.
# 1c: What do yo u  see as the key screening criteria?
Depo-Provera® use, inadequate calcium intake, lack of exercise and 
smoking were all identified as key screening criteria. While calcium intake and 
Depo-Provera® use were used most in screening, participants felt that smoking 
and lack of exercise were equally important for preventing osteoporosis.
H id : Do yo u  fo llo w  up w ith patients you  screen that you  fin d  are a t risk
fo r  osteoporosis?
Follow up was only practiced consistently with Depo-Provera® users.
Patients receiving an injection of Depo-Provera® at the three-month routine 
follow up visit are asked about calcium intake and supplementation. Other 
patients are routinely asked about diet, exercise, smoking and family history as 
general health questions during initial visits and annual exams.
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Question  #2: What are the m ost im portan t messages yo u  as a p rov ide r can 
g ive  patien ts about osteoporosis prevention?
The most important general m essage was that “Osteoporosis is 
preventable.’* Adequate calcium intake, exercise and not smoking were the 
health behaviors most important to address. Preventing osteoporosis at an early 
age was also important. One participant stated, "Start now to reduce problems 
later”.
Question #3: Which age group do you  beiieve is  m ost im portant fo r  
osteoporosis prevention?
No specific age group was identified as the most important for 
osteoporosis prevention; all ages were viewed as important. Many participants 
stated that although the teenage years are very important in preventing 
osteoporosis, this age group is not as  receptive to osteoporosis prevention 
information as older women are. One participant stated, “Sooner than later is 
best, but they [teens] don't listen as well”. Another participant stated, “When 
women start seeing symptoms, it’s like a wake-up call at menopause”.
Question #4: How does the num ber o f  patients seen p e r day influence y o u r  
educational practices?
Approximately half of the participants felt that the number of patients seen 
per day did not influence their educational practices. Osteoporosis prevention 
information was given, even when rushed for time. One participant stated, "the 
m essage is short, but I don’t eliminate it”. Participants who felt that the number
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of patients seen did influence their educational practices cited priority of the visit 
as the main factor for not educating about osteoporosis. “Prevention gets lost”, 
one participant stated. “Time is not specifically set aside for osteoporosis 
prevention, so [prevention] is the first to go when pressed for time", another 
stated.
Question  #5: Perceived barriers were identified; Do you  feei these are 
barriers? ( if  yes...) How do they influence yo u r educational practices?
#5a: “Lack o f  w ritten m aterials fo r  patients*’
Lack of materials was seen as a barrier to educating patients. Not having 
written materials limits education, and having a good educational tool would help 
to disseminate osteoporosis prevention information. Types of helpful 
educational materials were discussed (see Question # 6).
#5/>; “Osteoporosis prevention is  n o t supported through g ran ts”
Osteoporosis prevention not being supported through grants was not 
viewed as a direct barrier to providing osteoporosis information, but participants 
felt that practices may be indirectly impacted by what types of materials are 
available. The general belief that "having more money would be nice” was 
evident, not just for osteoporosis prevention practices, but overall. “Funds are 
scarce for everything”, one participant stated.
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#5c: “ Lack o f  receptiveness from  patien ts”
More comments were made regarding this question than any other. All 
felt strongly that the lack of receptiveness among patients was a major barrier, 
especially for younger women. This affects educational practices in many ways; 
some stated that it makes them work harder at educating, while others felt that if 
osteoporosis prevention information was not being received, it may be wasting 
time during an office visit. Comments included, “They don’t see osteoporosis as 
'here and now”’; “It’s hard, they are already filled up with other info, so it's too 
much already”; “..they seem receptive, but [education] may not translate into 
changing behavior”; “Teens don’t hear you”; “[Patient's view Is] Just give me the 
birth control and get me out of here”; and “in 20's and 30's, they’re more 
conscious”.
Question #6a: What k inds o f  educational too ls are you  using?
Most health care providers used verbal instruction for education. Some 
participants had brochures, but none were age appropriate, and seldom used 
with women 25 years and younger. One participant had a poster on the exam 
room wall, and a few used calcium source handouts. Others used an 
informational handout from the Depo-Provera® pharmaceutical company. One 
participant made her own hand out, which she felt was useful, but was not used 
by all providers In the clinic.
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M6b: What add itiona l too ls  do yo u  believe w ould be m ost he lp fu l in  
p rov id ing  Inform ation to  yo u r patients?
Participants were eager to give opinions on educational tools they felt 
would be helpful in educating women 25 years and younger. Videos were 
mentioned as  a possible educational tool that could be viewed while waiting. 
Other educational tools suggested included handouts, cards, and book markers. 
When considering these tools, many criteria were stated as  important, including:
• make it short, simple and easy
• have a 4“* to 6‘*’ grade level of reading
• include pictures of osteoporosis bone and/or women
• include all options of calcium sources; not Just dairy, but vegetable
sources as well
• make it one page or less
• must be age appropriate
Having calcium samples on hand was also suggested, and viewed as an 
incentive for young women to supplement their diets.
#6c: Where do yo u  obtain the Inform ation you  use to educate patients?
Educational information was obtained from conferences, the Dairy 
Council, and from the Depo-Provera® pharmaceutical company.
#6d: Could yo u  send  us the curren t educational too ls  you  have/use?
All participants using educational tools agreed to send copies of the 
materials.
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Question  #7; What else do yo u  want us to know? What comments, 
concerns, o r  questions do you  have about the questionnaire o r p rocess in 
general?
Many participants wanted to know when the information would be 
available to them, and what was going to come of the study. Many commented 
on the importance of osteoporosis prevention education. One participant 
reiterated the importance of the media and community being involved in 
educating young people in regard to osteoporosis prevention.
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CHAPTER V
The purpose of this study was to conduct an assessm ent of health care 
providers' knowledge, beliefs and practices regarding osteoporosis prevention in 
women 25 years and younger. In addition, barriers to disseminating 
osteoporosis prevention information and education were identified.
Summary of Findings
Knowledge and Beliefs
Results of this study indicate that most health care providers at Montana’s 
Title X Family Planning clinics believe that osteoporosis prevention is important 
and are well informed about the disease. Specifically, it can be said that most 
health care providers:
• Believe that attaining peak bone mass before the age of 30 is the 
preferred scenario for preventing osteoporosis (72,5%)
• Know that engaging in exercises such as weight lifting or walking are 
important for preventing osteoporosis for women 25 years and younger 
(94.2%)
• Recommend 1000 mg. or more for daily calcium intakes (89.4%)
• Believe the most important m essage about osteoporosis is that it is 
preventable
• View inadequate calcium intakes, lack of exercise, smoking, and the use
of Depo-Provera® for contraception as the most important risk factors in 
addressing the development of osteoporosis (more than 82%)
54
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
55
• Believe that all ages are Important for educating about osteoporosis 
prevention; females younger than 13 years were rated as important less 
often (66.7%) than females 13 years and older (more than 88%);
• Believe that they (providers) are the best source of osteoporosis 
prevention Information for women 25 years and younger (73.9%)
Practices
The responses to questions regarding health care providers’ practice
were more varied than responses to knowledge and belief questions.
Specifically it can be said that:
• The majority of patients seen by providers are 25 years and younger 
(62.38%)
• Screening criteria was reported as being used “never,” “rarely” or 
"sometimes” by over half of the respondents (59.4%), and under half 
reported using screening criteria "often” (40.6%)
• Screening practices were determined mainly by the reason for the visit; 
screening occurred more often during Initial visits and annual exams, and 
with patients using Depo-Provera®
• No assessm ent tool specific to osteoporosis risk was used; screening 
Information was obtained from nutritional Intake forms and health history 
forms, filled out during Initial visits or annual exams
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
56
• Depo-Provera® use, Inadequate calcium intakes, lack of exercise and 
smoking were seen as  the key screening criteria when screening young 
women for osteoporosis risks
• Verbal instruction was reported as the method used most often when 
providing prevention information (93,8%); brochures (46.2%) and calcium 
intake charts (40.0%) were the next most popular method; and almost half 
used a combination of verbal instruction with some other means of written 
material (49.1%); follow up telephone interviews clarified that current 
written material was viewed as insufficient and not relevant to women 25 
years and younger.
• Providers were consistent in their beliefs and practices; rankings of
behaviors or characteristics used as screening criteria are identical to
rankings of risk factors perceived to be important (refer to Tables 3 & 5,
and telephone interview question #1 c)
Barriers to Prevention
Lack of receptiveness of vouna women.
Health care providers identified lack of receptiveness of young women to 
prevention information as  a  major barrier to providing osteoporosis prevention 
information and education (81.2%), Specific barriers to women's receptiveness 
include:
• Disbelief of susceptibility (94.2%)
• Lack of knowledge of risk for their age group (89.9%)
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• Osteoporosis prevention is not a priority during an office visit (87.0%)
• Chronic disease prevention in general not a priority (87.0%)
Other barriers to providing osteoporosis prevention information.
Health care providers identified other limiting factors in their ability to 
provide osteoporosis prevention to women age 25 and younger. Of the barriers 
listed on the survey:
• Lack of written materials was the barrier identified most often (66.7%); 
during telephone interviews, providers suggested developing a short, 
easy-to-read, one-page handout for osteoporosis prevention education
• Not enough time with the patient was identified as a barrier by half of the 
providers (52.1%). However, a  discriminant analysis showed no 
statistical difference between health care providers’ perception of time 
and the number of patients seen per day; the mean score for patients 
seen per day was twelve for both groups. Telephone interview data 
affirmed the same number of providers (approximately half) perceived the 
number of patients seen per day a s  a barrier; participants who felt that the 
number of patients seen per day was a barrier eliminated osteoporosis 
prevention information when short on time; those who did not see  the 
number of patients seen per day as  a barrier continued to include 
education, even when time was limited.
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• Lack of professional education was identified by registered nurses as a 
barrier, while no nurse practitioner identified this a s  a barrier (p < .001 )
• Lack of grant support was identified by over half of the providers (52.1%). 
Telephone interviews clarified that health care providers did not see  this 
barrier as directly impacting their educational practices, but possibly 
indirectly affecting materials available to help educate women about 
osteoporosis prevention
Statistical Differences in Responses Based Uoon Aae. Title and Years in 
Practice
Chi square tests were conducted to determine differences in responses 
based on age, title, and years in practice. Statistical significance was detected 
in the following areas;
• Providers with titles in the "other” category rated the general importance 
of osteoporosis prevention as less important than did registered nurses or 
nurse practitioners. Of those who responded “not important” or 
“somewhat important," two were medical doctors and two were clinical 
directors
• Providers with titles in the “other” category rated the importance of 
education for teens (13 -19) as less important than did registered nurses 
or nurse practitioners. Of those who responded “not important” or
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“somewhat important," two were medical doctors, one was a clinical 
director, and one was a health educator
Nurses reported more often than nurse practitioners that they believed 
they lacked adequate education for providing osteoporosis prevention 
information
Discussion/Recommendations 
Health care providers at Montana’s Title X clinics have the opportunity to 
educate young women about osteoporosis prevention. Access to this target 
population is evident in that more than 60% of the patients seen at these primary 
and affiliated satellite clinics are young women 25 years or younger. And while, 
most providers are knowledgeable about osteoporosis prevention, believe it is 
an important issue to address for young women, and view themselves as a 
primary Information source for osteoporosis prevention information, only 40% 
routinely screen patients for osteoporosis risks. Furthermore, consistency in 
prevention efforts is lacking. It appears that several issues must be addressed 
in order for health care providers’ to capitalize on the opportunity to educate 
young women regarding osteoporosis prevention.
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Issue #1 : Women’s Lack of Receptiveness to Osteoporosis Prevention
Providers’ perceptions of young women’s lack of receptiveness to 
osteoporosis prevention information influences their practices. This perception 
Is supported by the literature which states “young women believe that it is 
unlikely that osteoporosis will develop in them. Women are also less concerned 
about osteoporosis, believe that they are less responsible for osteoporosis 
developing, and believe that osteoporosis is less serious than other common 
causes of morbidity and mortality in women” (Kasper et al. (1994), p.701).
Recommendation.
The researcher recommends the development and implementation of a 
survey of women 25 years and younger who are patients at Montana Title X 
Family Planning clinics. This survey would identify knowledge and attitudes 
regarding osteoporosis prevention, along with barriers to receiving information. 
Additional specific data regarding women’s receptiveness to osteoporosis 
prevention information can be collected through follow up focus groups and/or 
interviews. A study of patients’ perceptions regarding osteoporosis would 
ascertain a better understanding of the issue, and would assist researchers 
when developing and implementing effective osteoporosis prevention strategies 
for providers.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
61
Issue #2: Lack of Educational Materials
The lack of educational materials addressing osteoporosis prevention 
influences providers' practices. Supporting literature reveals that educational 
materials for use by health care providers need to be developed to improve 
osteoporosis prevention strategies (Lysen & Walker, 1997).
Recommendation.
The researcher recommends the development and implementation of 
educational materials specifically targeting women 25 years and younger, using 
health care providers’ suggestions obtained from this study. Relevant, age- 
appropriate educational tools such as  one-page handouts, posters and videos 
would increase osteoporosis prevention efforts. The survey of patients should 
take place before development begins, and health care providers should 
continue to be surveyed during the development of the materials. Focus groups 
and/or interviews with patients and health care providers will ensure that the 
materials are appropriate and useful, thus enhancing the efficacy of the tools. 
Combining educational materials with verbal instruction (already most often used 
by providers) would support prevention efforts, and increase efficacy of learning. 
In addition, the use of effective educational materials may assist those providers 
who eliminate osteoporosis education when pressed for time to provide 
information more consistently.
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issue #3: Lack of Education
The lack of education was a significant perceived barrier for registered 
nurses. Supporting literature reveals that poor preparation in school is a 
possible reason why health care practices have not focused on prevention 
(ORBD-NRC NEWS, Guidelines to Clinical Preventive Services, April 8, 1996).
Recommendation.
The researcher recommends continuing education for health care 
providers regarding osteoporosis prevention. Specifically, registered nurses will 
benefit, increasing their self efficacy for educating young women about 
osteoporosis. Their perception of lack of education as a barrier to providing 
prevention information may be reduced, or perhaps eliminated, and providers 
will educate young women more effectively and consistently.
Issue #4: No Assessment Tool Specific to Osteoporosis Risk
No screening tool specific to osteoporosis risk was used by any provider, 
and screening practices were inconsistent. Patients being seen for initial visits, 
annual exams and those receiving Depo-Provera® were given priority for 
osteoporosis risk screening.
Recommendation.
The researcher recommends the development and implementation of an 
assessm ent tool to screen for osteoporosis risk. Supporting literature reveals 
that risk assessm ents can provide valuable information for providers and
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improve osteoporosis prevention efforts (Lysen & Walker, 1997). Utilizing a risk 
assessm ent will increase consistency, and expand screening to those patients 
who are being seen for reasons other than an initial visit, annual exam , or a 
Depo-provera® injection. As recommended for the development of educational 
materials, health care providers should be involved in the development process 
for the risk assessm ent tool.
Issue #5: Providers' Titles and Their Perceptions of Osteoporosis Prevention 
Statistically significant findings regarding providers' titles and their 
perceptions of osteoporosis prevention warrant consideration. Two medical 
doctors and two clinical directors rated the general importance of osteoporosis 
prevention as “not important or only “somewhat important,” consistently more 
often than did registered nurses or nurse practitioners. Also, two medical 
doctors, one clinical director, and one health educator rated the importance of 
education for teens (13-19) as  less important than did registered nurses or nurse 
practitioners. These providers are in managerial and/or administrative positions, 
and may influence the practices of providers in their clinics. Supporting 
literature reveals that providers’ perceptions may be more influential than patient 
characteristics when making decisions regarding preventing and managing 
osteoporosis (Suarex-Almazor, Homik, Messina, and Davis, 1998, p. 1106).
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Recommendation.
The researcher recommends follow up interviews with administrative and 
managerial personnel at Montana Title X Family Planning clinics. The support 
and involvement of administration is extremely important for the effectiveness of 
osteoporosis prevention efforts. Personal interviews with medical doctors, 
clinical directors, and health educators will provide further understanding of their 
perceptions of the importance of osteoporosis prevention, and will assist 
researchers In improving osteoporosis prevention strategies.
Further Research
While the information obtained from this study is valuable information, it 
cannot be generalized to populations other than health care providers at 
Montana Title X Family Planning primary and affiliated satellite clinics.
Surveying health care providers practicing in settings other than Montana Title X 
clinics would provide additional, useful data. Knowledge, beliefs and practices 
of other health care providers in regard to osteoporosis prevention for women 25 
years and younger can be better understood, thus encouraging continued efforts 
of osteoporosis prevention strategies among all health care providers.
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Appendix A 
Montana Title X Primary and Satellite Clinics
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MONTANA TITLE X PRIMARY CLINICS
CITY & ZIP CODE ADDRESS PHONE
Billings 59711 Planned Parenthood of Billings, Inc. 
721 N. 29'^ (Admin. Office)
248-3636
248-3637
Bozeman 59715 Bridger Clinic, Inc.
300 N. Wilson, Suite 2001
587-0681
Butte 59701 Family Services Center 
25 W. Front
723-6507
Dillon 59725 Beaverhead County Family Planning 
1260 S. Atlantic
683-4771
Glendive 59330 Dawson County Family Planning 
207 W. Bell
377-2935
Great Falls 59401 Planned Parenthood of Great Falls 
1220 Central Ave.
454-3432
Hamilton 59840 Ravalli county Family Planning 
205 Bedford, Box 5018
375-6259
Havre 59501 Hill County Family Planning 
Room 112, College Park Plaza 
P.O. Box 166
265-2519
Helena 59601 Planned Parenthood of Helena 
1500 Cannon St.
443-7676
Kallspell 59901 Flathead County Family Planning 
723 S'" Avenue East
758-5756
Lewisto\wn 59457 Central Montana Family Planning 
224 W. Main St., Suite 603
538-8811
Libby 59923 Lincoln County Family Planning 
421 Montana 
P.O. Box 765
293-6291
Miles City 59301 Custer County Family Planning 
Courthouse Annex
233-3440
Missoula 89802 Planned Parenthood of Missoula 
219 E. Main St.
728-5561
728-5490
Poison 59860 Lake County Family Planning 
802 Main St., Suite A
883-7288
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wroNTAr4A  TITLE X SATELLITE CLINICS
CITY & 2IPCODE ADDRESS PHONE
Anaconda (Butte) 59711 Deer Lodge Co. Family Planning 115 
West Commercial St.
P.O. Box 970
563-7863
Baker (Glendive) 59313 Fallon CO. Family Planning
Box 820
202 S. 4"* St. W.
778-3331
Billings (Billings) 59102 Indian health Board 
915 Broadwater
245-7318
Boulder (Butte) 59632 Jefferson County Health Dept. 
214 S. Main
225-4231
Broadus (Miles City) 59317 Powder River Medical 
Box 325
436-2297
Chinook (Havre) 59538 Blaine Co. Family Planning 
419 Pennsylvania Ave.
357-2294
Columbia Falls (Kallspell) 
59912
Montana Peaks Bldg. 
123 6th St. West
758-5756
Deer Lodge (Butte) 59722 Powell Co. Family Planning 
305 Milwaukee
846-2420
Eureka (Libby) 59717 Eureka Family Planning 
Lincoln Co. Family Planning 
P.O. Box 765 Libby, MT 59923
293-6291
Harlowton (Lewistown) 
59036
Bair Memorial Clinic 
530 Third North West
632-4835
Livingston (Bozeman) 
59047
108 % W. Callendar, Apt. #3 587-0681
Malta (Havre) 59538 Phillips Co. Family Planning 
105 South 2"  ̂St. East 
P.O. Box 241
654-2521
Phillipsburg (Missoula) 
59858
Health Fitness Place 
144 W. Broadway
1-800-230-PLAN
Sidney (Glendive) 59270 Richland Co. Family Planning 
County Health Department 
221 5'” St. S.W.
482-2207
West Yellowstone 
(Bozeman) 59758
West Yellowstone Clinic 
236 Yellowstone St.
587-0681
Whitehall (Butte) 59632 Jefferson Co. Health Dept.
Attn; Whitehall
Box 872 Boulder. MT
287-3249
Wibaux (Glendive) 59353 Wibaux Co. Family Planning 
Wibaux Co. Courthouse
795-2485
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Appendix B 
Introductory Letter
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DEPARTM ENT OF 
PUBLIC HEALTH A N D  H U M A N  SERVICES
n X  \  M A RC RAC IC OT 
G O V E R N O R
LAURIE EKANCER 
DIRECTOR
gTATE OF MONTANA
February 26, 1999 
Dear Director:
As mentioned at the February IS"’ Met Net Council meeting, the Women’s Health 
Section (WHS) Title X Program has been granted funds to develop strategies for 
osteoporosis prevention targeting non-pregnant women 25 years or younger. WHS 
has contracted with Annie Sondag and Nancy Mulla, health educators at The University 
of Montana, to assist us in this project. The first step is to accurately identify health 
care providers' needs in relationship to osteoporosis prevention. Surveying staff 
regarding their practices and beliefs will identify those needs.
What We Need From You:
Identification of Staff to Be Surveved
• Please complete the attached form. Include the names and positions of all staff 
that provide counseling, education or information regarding osteoporosis 
prevention to non-pregnant clients 25 years or younger. In addition, provide the 
names and titles of staff at satellite clinics that provide these services.
• Return forms bv March 19“* to: Nancy Mulla, Department of Health and Human 
Performance, University of Montana, Missoula, MT 59812. A return envelope 
is enclosed for your convenience.
Ensure Return of Survevs
• Promote and encourage your staff to participate in the survey to be distributed 
May 1999.
What We Can Offer You:
• Your participation in this project will help to improve osteoporosis prevention 
efforts targeted toward women under the age of 25.
• Participation in this project, as indicated by completed surveys, will fulfill the Title 
X Internal Medical Audit Requirement due July 1999.
» Survey results will be sent to you on request.
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W e appreciate you taking time out of your busy schedule to help us!
If you have questions or concerns please contact;
Ellie Hardy, W omen’s Health Section. DPHHS. (406) 444-4348 - or - 
Annie Sondag or Nancy Mulla, Department of Health and Human Performance. 
University of Montana, (406) 243-5215; e-mail: cbeemer@ selway.um t.edu.
Sincerely,
Ü
Suzanne Nybo. MS 
Section Supervisor 
W omen’s Health Section 
Family/Community Health Bureau
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Appendix C 
Introductory Response Form
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E m p lo y e e  N am e____________________________T itle
1.________________________________________________
2. :___________
3  .____________________________________________________
4 ._________________________________________________
5 ._________________________________________________
6 .________________________________________
7 ._________________________________________________
8  ._________________________________________________
9._________________________________________________
10.,
11 ..
12 ._
13._
14._
15._
16._
17._
18._
19._
20.
PLEASE RETURN IN POSTAGE PAID ENVELOPE
Nancy Mulla, Dept, o f HHP, U niversily o f M ontana, M issoula, MT 59812
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Appendix D 
Telephone Interview Response Form
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July 16, 1999
Dear
This letter is to follow up on the Osteoporosis Prevention Survey that you 
completed recently. The project is coming along nicely, and I greatly appreciate 
your cooperation and participation! To further validate the survey findings, I am 
asking for a small amount of your time to conduct a telephone interview. I know 
your time is valuable and limited- the interview will take ten to twenty minutes, 
and can be scheduled at your convenience during your work schedule. The 
information received from this telephone interview will greatly help to utilize the 
survey results more effectively in regard to osteoporosis prevention.
Below is a  response form. P lease  fill it out and send it back in the self- 
addressed  postage paid envelope by A ugust 6 ,1999 . I will be contacting you in 
August to conduct the telephone interview. This interview will be confidential, 
and your name will not appear anywhere in the analysis of the interview data.
Again, I greatly appreciate your time in helping me to complete this project. I 
look forward to talking with you soon.
Sincerely,
Nancy Mulla 
Graduate Student 
University of Montana
Name Clinic location
Phone Number to call for Interview
Best Time for Interview appointment <Please circle best day & time to contact) 
M onday Tuesday W ednesday Thursday Friday
9:00AM-12:00PM 12:00-1:00PM 1:00-4:00PM 4:00-7:00PM
If only a specific  tim e w orks fo r you, p lease  ind icate  tim e and  day 
h e re :_________________
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Appendix E 
Questionnaire
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A SURVEY OF HEALTH CARE PROVIDERS* EXPERIENCES AND 
OPINIONS REGARDING OSTEOPOROSIS PREVENTION IN WOMEN
2S YEARS A M ) YOUNGER
Instnictioos: Please respond to the questions bv -filling in the blanks and marking the appropnate boxes.
3.
4.
In general, how would you rate the 
importance of osteoporosis prevention? 
Q not important Q important
Q somewhat inqjortant [] very inqiortant
In your opinion which of the following 
scenarios is preferred for osteoporosis 
prevention? (check one)
0 attaining peak bone mass before the 
age of 30
Q preventing bone iœs through calcium 
supplementation after the age of 30 
0 estrogen replacement ther^y during 
menopausal years
Rate each of the following risk foctors in 
terms of its importance in contributing to 
the devdopmem of osteoporosis.______
l-not important, 2-mmewhat important. 
3-imp(mant. 4-verv imrxnrtant
 inadequate calcium intake
 amenorrhea
 ethnicity
 lack of exercise
 smoking
 vitamin D deficiency
 oral contraceptive use
 excessive alcohol intake
 fomily history
 Depo-Provera® use
 disordered eating
 thin boned /  small frame
other ________
8 .
How receptive do you think women 25 
years and younger are to 
information/education regarding 
osteoporosis prevention?
[] not receptive [] receptive
11 smnewhat receptive [] very receptive
What is the most important osteoporosis 
prevention message to give women 25 
years and younger about plysical 
activity? (check one) 
n maintain good posture 
G engage in exercises such as w ei^  
lifting or walking 
G engage in exercises such as 
swimmmg or bimcling
How many milligrams of calcium would 
you recommend for women 25 years and 
younger?
_______ mg. daily
Rate each of the following age groups in 
terms of its importance in educating 
about osteoporosis prevention.________
l-not important. 2-somewhat important. 
3- important. 4-verv important
 pre-teenj^cr (8-12)
 teenager (13-19)
 early adulthood (20-40)
 mid life (41-65)
 elderly (66 & older)
Do you believe that you as a health care 
provider are the best source of 
osteoporosis prevention information for 
women 25 years and younger?
[] yes 11 no G not sure
If no or not sure who or what would be foe 
best source? ____
(Please complete questions on back.)
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10.
How often do you use screening criteria 
to determine v^ch patients receive 
information about osteoporosis 
prevention?
11. To what extent do you agree that the 
following are barriers to women's 
receptiveness to osteoporosis prevention 
information?
[} never 
ii rarely
[] sometimes 
[] often
If you use screening criteria, what patient 
behaviors or characteristics are included? 
(check ail that ai^ly)
 inadequate calcium intake
 amenorrhea
 ethnicity
 lack o f exercise
 smoking
 vitanun D deficiency
 oral contraceptive use
 excessive alctdiol intake
 fiunily hismiy
 Depo-Provera® use
 disordered eating
 thin bmred/smail fiame
other
To what extent do you agree that the 
following are barriers to you providing 
osteoporosis prevention information to 
women 25 vears or vouncer?
12 .
1-strongly disi^ree 2-disagree,
3- azree 4-sironeiv aeree
 not enough time with client
 not a priontv' for me during office
visit
 lack of education in my
professional trainn% prc^ram
 insufficient research making the
case for ostetqxtrosis prevention 
during early years
 lack of written materials for
patients (i.e. brochures)
 osteoporosis prevention is not
financially supported through grants
 ostcqporosis prevention is not
reimbursable through insurance
 osteoporosis prevention is not
supported by clinic administrators 
other______
13.
14.
1-strongly disagree 2-disagree.
3- agree 4-stronelv agree
 voting tvomen do not have
knowledge about the risks 
associated with osteqmrosis
 your% women don't believe they are
susceptible to osteoporosis
 osteoporosis prevcntitm is not a
priority ft>r the patient duripg the 
office visit
 chronic disease prevention in
general is not a priority for young 
women
 other_______________________
If you provide information r^arding 
osteoporosis prevention to women 25 
years and younger in what manner do you 
provide it? (check all that apply)
 question is not qpplicadile
 verbal instruction
 brochures
 informational videos
 informational booklets
 promotional handouts
 posters in office
 calcium intake charts
other_______________________
Your Title?
Years in Practice?_____
Female  Male___
A g e 20-29
 30-39
 40-49
 50 years & older
On average how many patients do you 
see per day? _____________
In general, what percentage of your 
patients are women 25 years and
younger? %
Thank you fo r your participation!
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Appendix F 
Telephone Interview Schedule
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Telephone Interview#____
Telephone number called_____________ ^
I nterviewee_____________________________
Location__________________________■_
Date________________
Time
1. a. How do you determine whether or not to screen a patient regarding 
osteoporosis?
b. What criteria are used in screening?
c. What do you see as the key screening criteria?
d. Do you follow up with patients you screen that you find are at risk for 
osteoporosis?
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2. W hat are the most important m essag es you as a  provider can give patients 
about osteoporosis prevention?
3. Which ag e  g roup  do you believe is m ost important for osteoporosis prevention 
education?
How does the num ber of patients se en  per day influence your educational 
practices?
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Perceived barriers w ere identified; Do you feel these  are  barriers? (If yes...) 
How do they influence your educational practices?
a. “Lack of written materials for patients”
b. “O steoporosis prevention is not supported through grants”
c. “Lack of receptiveness from patients"
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6. a. W hat kinds of educational tools are  you using?
b. W hat additional tools do you believe would be most helpful in providing 
information to your patients?
G. W here do you obtain the information you use  to educate patients?
d. Could you send us the current educational tools you have/use?
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W hat else do you want us to know? W hat comments, concerns, or questions 
do you have about the questionnaire or process in general?
Post-interview notes; 
General Impression:
Any specific them e/tone to interview?
Additional constructs that em erged not already noted?
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Appendix G 
Telephone interview Introduction and Conclusion
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Hello_________________________ , this Is Nancy Mulla from the University of Montana.
I'm calling to follow up on the Osteoporosis Prevention Questionnaire that you filled out 
for us. Is this a good time for you? My thesis chair requested that I tape this telephone 
conversation. This is a totally confidential interview, and your name will not be 
attached to any information given. I am the only person that hears the tape, and after I 
complete my thesis, the tape will be erased. Is this OK with you? Great.
The purpose of this interview is to clarify questionnaire results, and to provide 
additional information to DPHHS regarding your needs in providing osteoporosis 
prevention information to your patients 25 years and younger. The information you 
give is very important and valued, and your time is greatly appreciated! There is a 
series of questions I'll ask you. P lease answer as candidly as possible. If you have 
any questions, please stop me. OK? The first question is....................
Thank you very m uch,______________________ . Again, I really appreciate you
taking time out of your busy schedule to help me! Have a good day.
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Appendix H 
Institutional Review Board Approval
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THE UNIVEBSITY OF MONTANA
i n s t i t u t i o n a l  r e v ie w  b o a r d  (IRB) 0 0 1 -9 9
CHECKUST
Submit one completed copy of this Checklist, including any required attachments, for each project involving human subjects. 
The IRp meets monthly to evaluate proposals, and approral is granted for one academic ycu. See £RB Guidelines and 
F/ocedhner for details.
Project Director: ; e:.  Dept.: M f4 P_____ Phone: S'A I S ' '
Signature_____________________________________________ i_______ Date: / -  ( I - 9 f
( f
Co-Director(s): ______________________________ Dept.:  Phone:____
Project Title:
Project Description: T%v. pv^pescL 4 % n> .■
(in nonteehntcd laMuage>~ ' , T  , . , ' ,
A .vLv a vJ O.J r
. u  J  
Please pnmtie the dates requested below;
Date Submitted to IRB 
/ -  / / -
Projected Start Date Ending Date 
I X  - 5 1 -  ? ?
Studratsonly:. ^
Faculty Supervisor:______________________;________ Dept:______________Phone:.
Signature:______________________________________;_______________________________
(My sifnsMt* confinas tSst 1 have tesU the 1RS Qicffclin sad siischmenis sad agree that it aecutaieiy and adequately represents the planned 
tocasen and that I wdl supervise tab reseateh prejcct.)
Project D irecton Please con^iete page 2 of IRB Checklist, on back.
R)f lASUse Only
IRB Review and Determination:
^E xem pt from Review  Expedited/Administrative Review  Approved
 Conditional approval:___________________________________________________ i_______
. Resubmit proposal:.
.Disapproved:,
Signature/IRB Chair:  Date:
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THE UNIVERSITY OF MONTANA
INSTITUTIONAL REVIEW BOARD (IRB)OO (
CHECKUST
Submit one completed copy of this Checklist, including any required attachments, for each project involving human subjects. 
The IRB meets monthly to evaluate proposais, and approval is granted for one academic year. See JJtB Cuiddines and 
Frocedura for details.
Project Director: 4 ^  __________Dept.: # 4  P Phone: I S"
Signature , /jf ^  _ J ____________________________Date: 9 -  "Î - T 1
Gî-Director(s):___________  :_______Dept.: _  Phone:________
Project Title; <;p<4r op,;,-/•><:<; pjsr-J-t/x -̂îoA KW<rJ<> ___________
I .
ProjectOescription: Pwrpc'Sr is -k JrtvfJLrs
(in nontechnical language) ' 7  . , (7 ' 1 ^
.AjTi-WcLl, ^  r.j-M'.lT preLTi WLS izi ' fV.Tt.«̂  S K i p  TP , a  taLftgoni. s_____
OOwNa < r r u ,V r <  /r ^  TT Y  F 'h 'n  ,'c 5.
Please provide the dates reqoested̂ eJeŵ
Date Submitted to IRB Projected Start Date Ending Date
9  -  1C -  J i ■ 9 ' . ^ - 9 9 / 5 -  1 1 - 9 9
Students only:
Facully Supervisor:__________________:____________ Dept.: _ _ _ _ _ _ _ _ _  Phone:________
Signature;__________________________________________________ i___________________
(My tignsiute confirmi that I hava read the 1RS Cbcekiist and auaehments and agree that it accuntcly and adequately represcnu the planned 
researdi and tiu i I will awpervwe this tcscaicn project.)
Project Director: Please complete page 2 of IRB Checklist, on back.
For in s  Usa Only
IHB Review and Determination:
.^i^Exempt from Review _ _  Expedited/Administrative Review  Approved
 Conditional approval:___________________________________________________________
 Resubmit proposal;_____________________________________________________________
. Disapproved:,
Signature/IRB Chair: / M t f /   Date: f ~
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Project Inform ation
1. In your opinion, does this project meet the requirements for Resecavh Exem pt from  Review  as outlined 
in Section B o f the IRB Guidelines and Procedures?
^  Y es (Oamplau inrennttkm b«tow _  N o (Compile lofoniwJioii bek"
■ad aiMcli qtiesiienniiic/Siitinimcal) eed ■tudi IRS Swmmeiy, Item»)
2. Human Subjects. DesaibebriefN: v iewers tilLs—tklgrM—LO— I'.n.. ■
A v : ^ <  < L -fclr X  ------------------------
Are any of the following included? otf that appif.
 Minors (wwer. .  is)  -------------- . If YES, spedfy age ranecfs):______ ___________________
__ Members of physically, p^chologicaUy, or socially vulneraole population?
3. How are subjects selected/recruited? E^iaînhnmfh: .oHl ^  tiy^rr
4 - / 3  y / r  l u A ^ P T - r ---------------------------------------------------------   :--------------------
4. Identification of subjects in data.
^Anonymous, no identification ___ Identified by name and/or address or other
5. Subject matter or kind(s) of information to be compiled from/about subjects.
Describe briej^ 5l>lijTt4s_ lor a ^V^A iloL.V  ̂ L l ' c W  o a4
Is information on any of the following included? Cheek au that appfy.
_  Sexual behavior Dlega! comduct
_ _  Alcohol use/abuse _ _ _  Dnxg use/abuse
___ Inforinacioa about the subject that, if it became lutown outside toe research, could reasonable place the subject at risk 
of crbniaal or civil liability or be damaging to the subject's Gaaadai standing or employability.
6. Means of obtaining the information. Check oil that apply.
Field/Labofatorv observation Mail survey (Aiuch quutioniMlre/inutvmeat)
. ___ Tissue/Blood samphng __On«site survey (Aiuch qiMctionMimtnitnmeni)
_  Measurement of motions/actions __  Examine public documents, records, data, etc.
 lo person interviews/survey (Atuch qoeHionnai're/in«niiner.t)  Examine private documents, records, data, etc.
y  Telephone iaterviewi/survey (Atuch queMionnaire/indniinent) .^Usc of Standard educational tests, etc.
_  Other meaos fspedfvl:
7. Is a written consent form being used:  Yes (Aiuts «omr) _K.No
8. Will subject(s) receive an explanation of the research before and/or after the project?
^ Y e s  (Atiaeh copy)  No (e4cc
9. Is this part of your thesis or dissertation?  Yes _K.No
If YES ____  date you successfully presented your proposal to your committee;--------------------
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Appendix I 
Data Organization Grid
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QUESTION #
Category Data
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